CHOICE HOTELS INTERNATIONAL REPORTS SECOND QUARTER 2026 RESULTS

Choice Hotels reported Q2 revenue of $441M (vs. $426M) and adjusted diluted EPS of $2.02 (vs. $1.92), but GAAP net income fell to $64M (from $82M) and GAAP diluted EPS declined to $1.41 (from $1.75). U.S. RevPAR improved to +1.3% YoY and U.S. net rooms growth strengthened for the second consecutive quarter; however, full-year 2026 net income guidance was cut to $230–$241M (from $265–$275M) while adjusted EBITDA guidance was raised to $635–$650M (from $632–$647M). The company also returned $26M to shareholders via dividends and $113M via share repurchases in the first half, and has $475M in total available liquidity.

Analysis

The key market read-through is not the EPS cut; it is that Choice is choosing to spend into conversion and franchise retention rather than harvest margin. That is constructive only if the incremental marketing and tech spend lifts signing velocity and royalty rate over the next 1-3 quarters; otherwise it becomes a drag on reported earnings while leverage stays sticky. In the next few days, the stock may trade on the bottom-line revision, but the more durable signal is the EBITDA raise plus better room growth, which should support the multiple if it proves repeatable.

Competitive dynamics favor the large franchisors with the strongest distribution and lowest owner friction. If Choice can keep accelerating U.S. net room additions, the pressure lands first on similar midscale/economy platforms that compete on conversion economics rather than luxury brand power, with Wyndham the most obvious relative-value target. The second-order effect is that owners may demand better economics from peers, forcing the whole segment to spend more on technology, loyalty, and central reservation systems, which can temporarily compress margins industry-wide.

The contrarian risk is that the market may be over-discounting the accounting noise while underestimating the quality of the growth inflection. That said, this is not a clean de-leveraging story yet: asset sales are still a 2027 event, so any delay leaves the equity exposed to higher interest expense and little room for a RevPAR slowdown. The thesis breaks if U.S. RevPAR rolls over, room-growth momentum stalls, or the first monetization of owned hotels slips materially beyond 1H27.

Key Decisions for Investors

• Buy CHH only on a 3-5% post-earnings pullback; target 10-15% over 6-12 months if U.S. room-growth momentum and royalty-rate improvement persist. Exit if U.S. RevPAR turns negative for two consecutive quarters.
• Pair trade: long CHH / short WH for a 1-3 month relative-value setup. The trade works if Choice’s room-growth acceleration proves sustainable while Wyndham’s more mature domestic base re-rates slower; cover if CHH loses share in midscale/extended stay conversions.
• Do not chase the rally on day one: wait for the conference call to confirm 2027 asset-sale timing and no further increase in interest expense guidance. If management sounds cautious on monetization, treat any strength as a sell-the-pop event.
• For credit investors, monitor CHH spreads rather than equity beta; buy longer-duration paper only if leverage trends below 3.0x and asset-sale proceeds become visible. If spread widening follows any delay in hotel sales, the equity bull case weakens materially.